HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 143.55 million. The enterprise value is 189.93 million.

Market Cap	143.55M
Enterprise Value	189.93M

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.27 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	31.27M
Shares Outstanding	31.27M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-1.68%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	1.12%
Float	19.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.84
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	5.20
P/OCF Ratio	5.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 6.88.

EV / Earnings	-13.22
EV / Sales	2.44
EV / EBITDA	7.62
EV / EBIT	n/a
EV / FCF	6.88

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.78.

Current Ratio	1.00
Quick Ratio	0.71
Debt / Equity	0.78
Debt / EBITDA	2.55
Debt / FCF	2.30
Interest Coverage	-0.58

Financial Efficiency

Return on equity (ROE) is -16.42% and return on invested capital (ROIC) is -2.20%.

Return on Equity (ROE)	-16.42%
Return on Assets (ROA)	-1.81%
Return on Invested Capital (ROIC)	-2.20%
Return on Capital Employed (ROCE)	-4.04%
Weighted Average Cost of Capital (WACC)	9.90%
Revenue Per Employee	915,372
Profits Per Employee	-168,998
Employee Count	85
Asset Turnover	0.39
Inventory Turnover	2.18

Taxes

Income Tax	-586,261
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.33% in the last 52 weeks. The beta is 0.83, so TSX:HLS's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-3.33%
50-Day Moving Average	4.52
200-Day Moving Average	4.92
Relative Strength Index (RSI)	52.94
Average Volume (20 Days)	6,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 77.81 million and -14.36 million in losses. Loss per share was -0.45.

Revenue	77.81M
Gross Profit	55.27M
Operating Income	-5.76M
Pretax Income	-14.95M
Net Income	-14.36M
EBITDA	24.21M
EBIT	-5.76M
Loss Per Share	-0.45

Balance Sheet

The company has 17.21 million in cash and 63.59 million in debt, with a net cash position of -46.38 million or -1.48 per share.

Cash & Cash Equivalents	17.21M
Total Debt	63.59M
Net Cash	-46.38M
Net Cash Per Share	-1.48
Equity (Book Value)	81.76M
Book Value Per Share	2.49
Working Capital	175,878

Cash Flow

In the last 12 months, operating cash flow was 27.85 million and capital expenditures -256,838, giving a free cash flow of 27.60 million.

Operating Cash Flow	27.85M
Capital Expenditures	-256,838
Depreciation & Amortization	29.59M
Net Borrowing	-28.28M
Free Cash Flow	27.60M
FCF Per Share	0.88

Margins

Gross margin is 71.03%, with operating and profit margins of -7.41% and -18.46%.

Gross Margin	71.03%
Operating Margin	-7.41%
Pretax Margin	-19.22%
Profit Margin	-18.46%
EBITDA Margin	31.12%
EBIT Margin	-7.41%
FCF Margin	35.47%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	-0.10%
Earnings Yield	-10.01%
FCF Yield	19.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4